BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jackson JA, Kim EJ, Begley B, Cheeseman J, Harden T, Perez SD, Thomas S, Warshaw B, Kirk AD. Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. Am J Transplant. 2011;11:2228-2234. [PMID: 21812928 DOI: 10.1111/j.1600-6143.2011.03680.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 101] [Article Influence: 10.4] [Reference Citation Analysis]
Number Citing Articles
1 Sigdel TK, Yang JYC, Bestard O, Schroeder A, Hsieh SC, Liberto JM, Damm I, Geraedts ACM, Sarwal MM. A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring. PLoS One. 2019;14:e0220052. [PMID: 31365568 DOI: 10.1371/journal.pone.0220052] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
2 Blydt-hansen TD, Sharma A, Gibson IW, Mandal R, Wishart DS. Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell-Mediated Rejection in Children After Kidney Transplantation: Urinary Metabolomics and Transplant Rejection. American Journal of Transplantation 2014;14:2339-49. [DOI: 10.1111/ajt.12837] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
3 Singh M, Bindal G, Misra CS, Rath D. The era of Cas12 and Cas13 CRISPR-based disease diagnosis. Crit Rev Microbiol 2022;:1-16. [PMID: 35164636 DOI: 10.1080/1040841X.2021.2025041] [Reference Citation Analysis]
4 Rush DN. Subclinical Rejection: a Universally Held Concept? Curr Transpl Rep 2020;7:163-8. [DOI: 10.1007/s40472-020-00290-2] [Reference Citation Analysis]
5 Blydt-Hansen TD, Sharma A, Gibson IW, Wiebe C, Sharma AP, Langlois V, Teoh CW, Rush D, Nickerson P, Wishart D, Ho J. Validity and utility of urinary CXCL10/Cr immune monitoring in pediatric kidney transplant recipients. Am J Transplant 2021;21:1545-55. [PMID: 33034126 DOI: 10.1111/ajt.16336] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Filippone EJ, Gulati R, Farber JL. Noninvasive Assessment of the Alloimmune Response in Kidney Transplantation. Advances in Chronic Kidney Disease 2021;28:548-60. [DOI: 10.1053/j.ackd.2021.08.002] [Reference Citation Analysis]
7 Kim JE, Han A, Lee H, Ha J, Kim YS, Han SS. Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome. BMC Nephrol 2019;20:212. [PMID: 31182046 DOI: 10.1186/s12882-019-1407-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
8 Hricik DE, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, Riggs M. Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am J Transplant. 2013;13:2634-2644. [PMID: 23968332 DOI: 10.1111/ajt.12426] [Cited by in Crossref: 153] [Cited by in F6Publishing: 130] [Article Influence: 17.0] [Reference Citation Analysis]
9 Crescioli C. Chemokines and transplant outcome. Clinical Biochemistry 2016;49:355-62. [DOI: 10.1016/j.clinbiochem.2015.07.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
10 Gao J, Wu L, Zhao Y, Hong Q, Feng Z, Chen X. Cxcl10 deficiency attenuates renal interstitial fibrosis through regulating epithelial-to-mesenchymal transition. Exp Cell Res 2022;410:112965. [PMID: 34896075 DOI: 10.1016/j.yexcr.2021.112965] [Reference Citation Analysis]
11 Faddoul G, Nadkarni GN, Bridges ND, Goebel J, Hricik DE, Formica R, Menon MC, Morrison Y, Murphy B, Newell K, Nickerson P, Poggio ED, Rush D, Heeger PS; CTOT-17 consortium. Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17. Transplantation. 2018;102:673-680. [PMID: 29189482 DOI: 10.1097/tp.0000000000002026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
12 Handschin J, Hirt-Minkowski P, Hönger G, Mitrovic S, Savic Prince S, Ho J, Nickerson P, Schaub S. Technical Considerations and Confounders for Urine CXCL10 Chemokine Measurement. Transplant Direct 2020;6:e519. [PMID: 32047847 DOI: 10.1097/TXD.0000000000000959] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
13 Mehta R, Cherikh W, Sood P, Hariharan S. Kidney allograft surveillance biopsy practices across US transplant centers: A UNOS survey. Clin Transplant 2017;31. [PMID: 28251702 DOI: 10.1111/ctr.12945] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
14 Ong S, Mannon RB. Genomic and proteomic fingerprints of acute rejection in peripheral blood and urine. Transplant Rev (Orlando). 2015;29:60-67. [PMID: 25542607 DOI: 10.1016/j.trre.2014.12.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
15 Weseslindtner L, Hedman L, Wang Y, Strassl R, Helanterä I, Aberle SW, Bond G, Hedman K. Longitudinal assessment of the CXCL10 blood and urine concentration in kidney transplant recipients with BK polyomavirus replication-a retrospective study. Transpl Int 2020;33:555-66. [PMID: 31981424 DOI: 10.1111/tri.13584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Mohammadi MH, Kariminik A. CC and CXC chemokines play key roles in the development of polyomaviruses related pathological conditions. Virol J 2021;18:111. [PMID: 34082771 DOI: 10.1186/s12985-021-01582-4] [Reference Citation Analysis]
17 Merhi B, Bayliss G, Gohh RY. Role for urinary biomarkers in diagnosis of acute rejection in the transplanted kidney. World J Transplant 2015; 5(4): 251-260 [PMID: 26722652 DOI: 10.5500/wjt.v5.i4.251] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
18 Ho J, Rush DN, Krokhin O, Antonovici M, Gao A, Bestland J, Wiebe C, Hiebert B, Rigatto C, Gibson IW, Wilkins JA, Nickerson PW. Elevated Urinary Matrix Metalloproteinase-7 Detects Underlying Renal Allograft Inflammation and Injury. Transplantation 2016;100:648-54. [DOI: 10.1097/tp.0000000000000867] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
19 Jamshaid F, Froghi S, Di Cocco P, Dor FJ. Novel non-invasive biomarkers diagnostic of acute rejection in renal transplant recipients: A systematic review. Int J Clin Pract. 2018;e13220. [PMID: 30011113 DOI: 10.1111/ijcp.13220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
20 Millán O, Budde K, Sommerer C, Aliart I, Rissling O, Bardaji B, Matz M, Zeier M, Silva I, Guirado L, Brunet M. Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation. Br J Clin Pharmacol 2017;83:2636-50. [PMID: 28880456 DOI: 10.1111/bcp.13399] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
21 Ho J, Wiebe C, Gibson IW, Rush DN, Nickerson PW. Immune Monitoring of Kidney Allografts. American Journal of Kidney Diseases 2012;60:629-40. [DOI: 10.1053/j.ajkd.2012.01.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
22 Lubetzky M, Bao Y, O Broin P, Marfo K, Ajaimy M, Aljanabi A, de Boccardo G, Golden A, Akalin E. Genomics of BK viremia in kidney transplant recipients. Transplantation. 2014;97:451-456. [PMID: 24310299 DOI: 10.1097/01.tp.0000437432.35227.3e] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
23 Neujahr DC, Uppal K, Force SD, Fernandez F, Lawrence C, Pickens A, Bag R, Lockard C, Kirk AD, Tran V. Bile acid aspiration associated with lung chemical profile linked to other biomarkers of injury after lung transplantation. Am J Transplant. 2014;14:841-848. [PMID: 24666830 DOI: 10.1111/ajt.12631] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
24 Gao J, Wu L, Wang S, Chen X. Role of Chemokine (C-X-C Motif) Ligand 10 (CXCL10) in Renal Diseases. Mediators Inflamm 2020;2020:6194864. [PMID: 32089645 DOI: 10.1155/2020/6194864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Mannon RB, Armstrong B, Stock PG, Mehta AK, Farris AB, Watson N, Morrison Y, Sarwal M, Sigdel T, Bridges N, Robien M, Newell KA, Larsen CP. Avoidance of CNI and steroids using belatacept-Results of the Clinical Trials in Organ Transplantation 16 trial. Am J Transplant 2020;20:3599-608. [PMID: 32558199 DOI: 10.1111/ajt.16152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Moreau A, Varey E, Anegon I, Cuturi MC. Effector mechanisms of rejection. Cold Spring Harb Perspect Med. 2013;3. [PMID: 24186491 DOI: 10.1101/cshperspect.a015461] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 8.1] [Reference Citation Analysis]
27 Mockler C, Sharma A, Gibson IW, Gao A, Wong A, Ho J, Blydt-Hansen TD. The prognostic value of urinary chemokines at 6 months after pediatric kidney transplantation. Pediatr Transplant 2018;22:e13205. [PMID: 29733487 DOI: 10.1111/petr.13205] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Nguyen VD, Van Nguyen H, Seo JW, Lee SH, Seo TS. Prediction of acute rejection in kidney transplanted patients based on the point-of-care isothermal molecular diagnostics platform. Biosens Bioelectron 2021;199:113877. [PMID: 34920227 DOI: 10.1016/j.bios.2021.113877] [Reference Citation Analysis]
29 Chong AS, Alegre ML. The impact of infection and tissue damage in solid-organ transplantation. Nat Rev Immunol. 2012;12:459-471. [PMID: 22627862 DOI: 10.1038/nri3215] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 9.1] [Reference Citation Analysis]
30 Daly KP, Seifert ME, Chandraker A, Zurakowski D, Nohria A, Givertz MM, Karumanchi SA, Briscoe DM. VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients. J Heart Lung Transplant 2013;32:120-8. [PMID: 23260712 DOI: 10.1016/j.healun.2012.09.030] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
31 van Duijl TT, Soonawala D, de Fijter JW, Ruhaak LR, Cobbaert CM. Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury. Clin Proteomics 2021;18:10. [PMID: 33618665 DOI: 10.1186/s12014-021-09315-z] [Reference Citation Analysis]
32 Tinel C, Devresse A, Vermorel A, Sauvaget V, Marx D, Avettand-Fenoel V, Amrouche L, Timsit MO, Snanoudj R, Caillard S, Moulin B, Olagne J, Essig M, Gwinner W, Naesens M, Marquet P, Legendre C, Terzi F, Rabant M, Anglicheau D. Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection. Am J Transplant 2020;20:3462-76. [PMID: 32342614 DOI: 10.1111/ajt.15959] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
33 Sigdel TK, Bestard O, Salomonis N, Hsieh SC, Torras J, Naesens M, Tran TQ, Roedder S, Sarwal MM. Intragraft Antiviral-Specific Gene Expression as a Distinctive Transcriptional Signature for Studies in Polyomavirus-Associated Nephropathy. Transplantation 2016;100:2062-70. [PMID: 27140517 DOI: 10.1097/TP.0000000000001214] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
34 Crespo E, Cravedi P, Martorell J, Luque S, Melilli E, Cruzado JM, Jarque M, Meneghini M, Manonelles A, Donadei C, Lloberas N, Gomà M, Grinyó JM, Heeger P, Bestard O. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients. Kidney Int 2017;92:201-13. [PMID: 28274484 DOI: 10.1016/j.kint.2016.12.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
35 Marx D, Metzger J, Olagne J, Belczacka I, Faguer S, Colombat M, Husi H, Mullen W, Gwinner W, Caillard S. Proteomics in Kidney Allograft Transplantation—Application of Molecular Pathway Analysis for Kidney Allograft Disease Phenotypic Biomarker Selection. Prot Clin Appl 2019;13:1800091. [DOI: 10.1002/prca.201800091] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
36 Popik W, Khatua AK, Fabre NF, Hildreth JEK, Alcendor DJ. BK Virus Replication in the Glomerular Vascular Unit: Implications for BK Virus Associated Nephropathy. Viruses 2019;11:E583. [PMID: 31252545 DOI: 10.3390/v11070583] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
37 Safa K, Magee CN, Azzi J. A critical review of biomarkers in kidney transplantation: . Current Opinion in Nephrology and Hypertension 2017;26:509-15. [DOI: 10.1097/mnh.0000000000000361] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Ho J, Rush DN, Nickerson PW. Urinary biomarkers of renal transplant outcome: . Current Opinion in Organ Transplantation 2015;20:476-81. [DOI: 10.1097/mot.0000000000000208] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
39 Rabant M, Amrouche L, Lebreton X, Aulagnon F, Benon A, Sauvaget V, Bonifay R, Morin L, Scemla A, Delville M, Martinez F, Timsit MO, Duong Van Huyen JP, Legendre C, Terzi F, Anglicheau D. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection. J Am Soc Nephrol. 2015;26:2840-2851. [PMID: 25948873 DOI: 10.1681/asn.2014080797] [Cited by in Crossref: 64] [Cited by in F6Publishing: 33] [Article Influence: 9.1] [Reference Citation Analysis]
40 Arnau A, Benito-Hernández A, Ramos-Barrón MA, García-Unzueta MT, Gómez-Román JJ, Gómez-Ortega JM, López-Hoyos M, San Segundo D, Ruiz JC, Rodrigo E. Urinary C-X-C Motif Chemokine 10 Is Related to Acute Graft Lesions Secondary to T Cell- and Antibody-Mediated Damage. Ann Transplant 2021;26:e929491. [PMID: 33686050 DOI: 10.12659/AOT.929491] [Reference Citation Analysis]
41 Venner JM, Hidalgo LG, Famulski KS, Chang J, Halloran PF. The Molecular Landscape of Antibody-Mediated Kidney Transplant Rejection: Evidence for NK Involvement Through CD16a Fc Receptors: Molecular Phenotype of ABMR. American Journal of Transplantation 2015;15:1336-48. [DOI: 10.1111/ajt.13115] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 10.7] [Reference Citation Analysis]
42 Mehta R, Sood P, Hariharan S. Subclinical Rejection in Renal Transplantation: Reappraised. Transplantation 2016;100:1610-8. [PMID: 26985747 DOI: 10.1097/TP.0000000000001163] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 5.8] [Reference Citation Analysis]
43 Glorie LL, Verhulst A, Matheeussen V, Baerts L, Magielse J, Hermans N, D'Haese PC, De Meester I, De Beuf A. DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2012;303:F681-8. [PMID: 22718884 DOI: 10.1152/ajprenal.00075.2012] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 7.4] [Reference Citation Analysis]
44 Malvezzi P, Fischman C, Rigault G, Jacob MC, Raskovalova T, Jouve T, Janbon B, Rostaing L, Cravedi P. Switching renal transplant recipients to belatacept therapy: results of a real-life gradual conversion protocol. Transpl Immunol 2019;56:101207. [PMID: 31071442 DOI: 10.1016/j.trim.2019.04.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
45 Tinel C, Vermorel A, Picciotto D, Morin L, Devresse A, Sauvaget V, Lebreton X, Aouni L, Prié D, Brabant S, Avettand-Fenoel V, Scemla A, Timsit MO, Snanoudj R, Legendre C, Terzi F, Rabant M, Anglicheau D. Deciphering the Prognostic and Predictive Value of Urinary CXCL10 in Kidney Recipients With BK Virus Reactivation. Front Immunol 2020;11:604353. [PMID: 33362789 DOI: 10.3389/fimmu.2020.604353] [Reference Citation Analysis]
46 Knight SR, Thorne A, Lo Faro ML. Donor-specific Cell-free DNA as a Biomarker in Solid Organ Transplantation. A Systematic Review. Transplantation. 2019;103:273-283. [PMID: 30308576 DOI: 10.1097/tp.0000000000002482] [Cited by in Crossref: 63] [Cited by in F6Publishing: 31] [Article Influence: 21.0] [Reference Citation Analysis]
47 Lamarche C, Sharma AK, Goldberg A, Wang L, Blydt-Hansen TD. Biomarker implementation: Evaluation of the decision-making impact of CXCL10 testing in a pediatric cohort. Pediatr Transplant 2021;25:e13908. [PMID: 33155737 DOI: 10.1111/petr.13908] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Lisboa LF, Egli A, Fairbanks J, O'shea D, Manuel O, Husain S, Kumar D, Humar A. CCL8 and the Immune Control of Cytomegalovirus in Organ Transplant Recipients: Cytomegalovirus Immune Containment and CCL8. American Journal of Transplantation 2015;15:1882-92. [DOI: 10.1111/ajt.13207] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
49 Hirt-Minkowski P, Rush DN, Gao A, Hopfer H, Wiebe C, Nickerson PW, Schaub S, Ho J. Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome. Transplantation 2016;100:1988-96. [PMID: 27548845 DOI: 10.1097/TP.0000000000001304] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
50 An P, Sáenz Robles MT, Duray AM, Cantalupo PG, Pipas JM. Human polyomavirus BKV infection of endothelial cells results in interferon pathway induction and persistence. PLoS Pathog 2019;15:e1007505. [PMID: 30620752 DOI: 10.1371/journal.ppat.1007505] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
51 Siegl J, Nikolin C, Phung NL, Thoms S, Blume C, Mayer G. Split-Combine Click-SELEX Reveals Ligands Recognizing the Transplant Rejection Biomarker CXCL9. ACS Chem Biol 2022. [PMID: 35018777 DOI: 10.1021/acschembio.1c00789] [Reference Citation Analysis]
52 Lo DJ, Kaplan B, Kirk AD. Biomarkers for kidney transplant rejection. Nat Rev Nephrol. 2014;10:215-225. [PMID: 24445740 DOI: 10.1038/nrneph.2013.281] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 10.6] [Reference Citation Analysis]
53 Guzzi F, Cirillo L, Buti E, Becherucci F, Errichiello C, Roperto RM, Hunter JP, Romagnani P. Urinary Biomarkers for Diagnosis and Prediction of Acute Kidney Allograft Rejection: A Systematic Review. Int J Mol Sci 2020;21:E6889. [PMID: 32961825 DOI: 10.3390/ijms21186889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
54 Gielis EM, Anholts JDH, van Beelen E, Haasnoot GW, De Fijter HW, Bajema I, Heidt S, van de Vrie M, Hilbrands LB, Mallat MJK, Ledeganck KJ, Claas FHJ, Eikmans M. A Combined microRNA and Chemokine Profile in Urine to Identify Rejection After Kidney Transplantation. Transplant Direct 2021;7:e711. [PMID: 34131583 DOI: 10.1097/TXD.0000000000001169] [Reference Citation Analysis]
55 Prytuła A, van Gelder T. Clinical aspects of tacrolimus use in paediatric renal transplant recipients. Pediatr Nephrol 2019;34:31-43. [DOI: 10.1007/s00467-018-3892-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
56 Yatim KM, Azzi JR. Novel Biomarkers in Kidney Transplantation. Seminars in Nephrology 2022;42:2-13. [DOI: 10.1016/j.semnephrol.2022.01.007] [Reference Citation Analysis]
57 Crowley LE, Mekki M, Chand S. Biomarkers and Pharmacogenomics in Kidney Transplantation. Mol Diagn Ther 2018;22:537-50. [PMID: 29971647 DOI: 10.1007/s40291-018-0349-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
58 Kim SC, Page EK, Knechtle SJ. Urine proteomics in kidney transplantation. Transplant Rev (Orlando). 2014;28:15-20. [PMID: 24321302 DOI: 10.1016/j.trre.2013.10.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
59 van den Bosch TPP, Hilbrands LB, Kraaijeveld R, Litjens NHR, Rezaee F, Nieboer D, Steyerberg EW, van Gestel JA, Roelen DL, Clahsen-van Groningen MC, Baan CC, Rowshani AT. Pretransplant Numbers of CD16+ Monocytes as a Novel Biomarker to Predict Acute Rejection After Kidney Transplantation: A Pilot Study. Am J Transplant 2017;17:2659-67. [PMID: 28332287 DOI: 10.1111/ajt.14280] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
60 Brunet M, Shipkova M, van Gelder T, Wieland E, Sommerer C, Budde K, Haufroid V, Christians U, López-Hoyos M, Barten MJ. Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation. Ther Drug Monit. 2016;38 Suppl 1:S1-S20. [PMID: 26977997 DOI: 10.1097/ftd.0000000000000287] [Cited by in Crossref: 56] [Cited by in F6Publishing: 18] [Article Influence: 9.3] [Reference Citation Analysis]
61 Mühlbacher J, Doberer K, Kozakowski N, Regele H, Camovic S, Haindl S, Bond G, Haslacher H, Eskandary F, Reeve J, Böhmig GA, Wahrmann M. Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft Recipients. Front Med (Lausanne) 2020;7:114. [PMID: 32328494 DOI: 10.3389/fmed.2020.00114] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
62 Venner JM, Famulski KS, Badr D, Hidalgo LG, Chang J, Halloran PF. Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands. Am J Transplant 2014;14:2565-76. [PMID: 25219326 DOI: 10.1111/ajt.12946] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 7.8] [Reference Citation Analysis]
63 Hirt-Minkowski P, Ho J, Gao A, Amico P, Koller MT, Hopfer H, Rush DN, Nickerson PW, Schaub S. Prediction of Long-term Renal Allograft Outcome By Early Urinary CXCL10 Chemokine Levels. Transplant Direct 2015;1:e31. [PMID: 27500231 DOI: 10.1097/TXD.0000000000000537] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
64 Brinkman C, Burrell B, Scalea J, Bromberg JS. Transplantation tolerance. Methods Mol Biol. 2013;1034:85-101. [PMID: 23775732 DOI: 10.1007/978-1-62703-493-7_4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Gandolfini I, Harris C, Abecassis M, Anderson L, Bestard O, Comai G, Cravedi P, Cremaschi E, Duty JA, Florman S, Friedewald J, La Manna G, Maggiore U, Moran T, Piotti G, Purroy C, Jarque M, Nair V, Shapiro R, Reid-Adam J, Heeger PS. Rapid Biolayer Interferometry Measurements of Urinary CXCL9 to Detect Cellular Infiltrates Noninvasively After Kidney Transplantation. Kidney Int Rep 2017;2:1186-93. [PMID: 29270527 DOI: 10.1016/j.ekir.2017.06.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
66 Erpicum P, Hanssen O, Weekers L, Lovinfosse P, Meunier P, Tshibanda L, Krzesinski JM, Hustinx R, Jouret F. Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples. Clin Kidney J 2017;10:106-15. [PMID: 28643819 DOI: 10.1093/ckj/sfw077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
67 Övünç Hacıhamdioğlu D, Zeybek C, Gök F, Pekel A, Muşabak U. Elevated Urinary T Helper 1 Chemokine Levels in Newly Diagnosed Hypertensive Obese Children. J Clin Res Pediatr Endocrinol 2015;7:175-82. [PMID: 26831550 DOI: 10.4274/jcrpe.1917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
68 Demmers MW, Baan CC, van Beelen E, Ijzermans JN, Weimar W, Rowshani AT. Differential effects of activated human renal epithelial cells on T-cell migration. PLoS One 2013;8:e64916. [PMID: 23717673 DOI: 10.1371/journal.pone.0064916] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
69 Chong S, Antoni M, Macdonald A, Reeves M, Harber M, Magee CN. BK virus: Current understanding of pathogenicity and clinical disease in transplantation. Rev Med Virol 2019;29:e2044. [PMID: 30958614 DOI: 10.1002/rmv.2044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
70 Schley G, Köberle C, Manuilova E, Rutz S, Forster C, Weyand M, Formentini I, Kientsch-Engel R, Eckardt KU, Willam C. Comparison of Plasma and Urine Biomarker Performance in Acute Kidney Injury. PLoS One. 2015;10:e0145042. [PMID: 26669323 DOI: 10.1371/journal.pone.0145042] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 7.4] [Reference Citation Analysis]
71 Islam SA, Medoff BD, Luster AD. Chemokine and Chemokine Receptor Analysis. In: Detrick B, Schmitz JL, Hamilton RG, editors. Manual of Molecular and Clinical Laboratory Immunology. Washington: ASM Press; 2016. pp. 343-56. [DOI: 10.1128/9781555818722.ch37] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
72 van Gelder T. Biomarkers in solid organ transplantation. Br J Clin Pharmacol 2017;83:2602-4. [PMID: 28880407 DOI: 10.1111/bcp.13391] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
73 Raza A, Firasat S, Khaliq S, Khan AR, Mahmood S, Aziz T, Mubarak M, Naqvi SAA, Rizvi SAH, Abid A. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Levels and Its Association with Renal Allograft Rejection. Immunological Investigations 2017;46:251-62. [DOI: 10.1080/08820139.2016.1248559] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
74 Başak Oktay S, Akbaş SH, Yilmaz VT, Özen Küçükçetin İ, Toru HS, Yücel SG. Association Between Graft Function and Urine CXCL10 and Acylcarnitines Levels in Kidney Transplant Recipients. Lab Med 2021:lmab049. [PMID: 34388247 DOI: 10.1093/labmed/lmab049] [Reference Citation Analysis]
75 Kaminski MM, Alcantar MA, Lape IT, Greensmith R, Huske AC, Valeri JA, Marty FM, Klämbt V, Azzi J, Akalin E, Riella LV, Collins JJ. A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection. Nat Biomed Eng 2020;4:601-9. [PMID: 32284553 DOI: 10.1038/s41551-020-0546-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
76 Calarota SA, Aberle JH, Puchhammer-Stöckl E, Baldanti F. Approaches for monitoring of non virus-specific and virus-specific T-cell response in solid organ transplantation and their clinical applications. J Clin Virol. 2015;70:109-119. [PMID: 26305832 DOI: 10.1016/j.jcv.2015.07.299] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
77 Raza A, Firasat S, Khaliq S, Aziz T, Mubarak M, Naqvi SAA, Mehdi SQ, Rizvi SA, Abid A. The association of urinary interferon-gamma inducible protein-10 (IP10/CXCL10) levels with kidney allograft rejection. Inflamm Res 2017;66:425-32. [DOI: 10.1007/s00011-017-1025-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
78 Cravedi P, Heeger PS. Immunologic monitoring in transplantation revisited. Curr Opin Organ Transplant. 2012;17:26-32. [PMID: 22186089 DOI: 10.1097/mot.0b013e32834ee402] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
79 Millán O, Rovira J, Guirado L, Espinosa C, Budde K, Sommerer C, Piñeiro GJ, Diekmann F, Brunet M. Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation. Clin Immunol 2021;229:108792. [PMID: 34217849 DOI: 10.1016/j.clim.2021.108792] [Reference Citation Analysis]
80 Modena BD, Kurian SM, Gaber LW, Waalen J, Su AI, Gelbart T, Mondala TS, Head SR, Papp S, Heilman R, Friedewald JJ, Flechner SM, Marsh CL, Sung RS, Shidban H, Chan L, Abecassis MM, Salomon DR. Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes. Am J Transplant 2016;16:1982-98. [PMID: 26990570 DOI: 10.1111/ajt.13728] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 9.3] [Reference Citation Analysis]
81 Bruneau S, Wedel J, Fakhouri F, Nakayama H, Boneschansker L, Irimia D, Daly KP, Briscoe DM. Translational implications of endothelial cell dysfunction in association with chronic allograft rejection. Pediatr Nephrol 2016;31:41-51. [PMID: 25903640 DOI: 10.1007/s00467-015-3094-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
82 Yin WY, Lee MC, Huang HB, Lu MC. Increased gene expression of TGF-β in peripheral blood mononuclear cells from renal transplant patients with polyomavirus BK viremia. Clin Transplant 2016;30:393-8. [PMID: 26783039 DOI: 10.1111/ctr.12698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
83 Handschin J, Wehmeier C, Amico P, Hopfer H, Dickenmann M, Schaub S, Hirt-Minkowski P. Urinary CXCL10 Measurement in Late Renal Allograft Biopsies Predicts Outcome Even in Histologically Quiescent Patients. Transplant Proc 2021;53:2168-79. [PMID: 34419254 DOI: 10.1016/j.transproceed.2021.07.013] [Reference Citation Analysis]
84 García-Covarrubias L, Ventura E, Soto V, González E, García A, Aguilar JC, Torres JM, Hinojosa H, Fragoso P, De Los Santos J, Ortuño D, San Cristóbal P, Díliz H. Lack of Association Between Elevated Urinary Levels of Interleukin-10 and Interferon Gamma With the Presence of Inflammation in Kidney Transplant Recipients. Transplant Proc 2016;48:583-7. [PMID: 27110008 DOI: 10.1016/j.transproceed.2016.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
85 Blydt-Hansen TD, Gibson IW, Gao A, Dufault B, Ho J. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation. Transplantation. 2015;99:797-804. [PMID: 25222013 DOI: 10.1097/tp.0000000000000419] [Cited by in Crossref: 38] [Cited by in F6Publishing: 16] [Article Influence: 5.4] [Reference Citation Analysis]
86 Christians U, Klawitter J, Klawitter J. Biomarkers in Transplantation--Proteomics and Metabolomics. Ther Drug Monit 2016;38 Suppl 1:S70-4. [PMID: 26418702 DOI: 10.1097/FTD.0000000000000243] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
87 Kowalewska J, Okoń K, Szynaka B, Naumnik B. Expression of macrophage markers in cryoglobulinemic glomerulonephritis - a possible role of CXCL9. Adv Med Sci 2013;58:394-400. [PMID: 24084359 DOI: 10.2478/ams-2013-0030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
88 Anglicheau D, Naesens M, Essig M, Gwinner W, Marquet P. Establishing Biomarkers in Transplant Medicine: A Critical Review of Current Approaches. Transplantation. 2016;100:2024-2038. [PMID: 27479159 DOI: 10.1097/tp.0000000000001321] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 8.2] [Reference Citation Analysis]
89 Ho J, Sharma A, Mandal R, Wishart DS, Wiebe C, Storsley L, Karpinski M, Gibson IW, Nickerson PW, Rush DN. Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10. Transplant Direct 2016;2:e78. [PMID: 27500268 DOI: 10.1097/TXD.0000000000000589] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
90 Rabant M, Amrouche L, Morin L, Bonifay R, Lebreton X, Aouni L, Benon A, Sauvaget V, Le Vaillant L, Aulagnon F, Sberro R, Snanoudj R, Mejean A, Legendre C, Terzi F, Anglicheau D. Early Low Urinary CXCL9 and CXCL10 Might Predict Immunological Quiescence in Clinically and Histologically Stable Kidney Recipients. Am J Transplant 2016;16:1868-81. [PMID: 26694099 DOI: 10.1111/ajt.13677] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
91 Xu X, Huang H, Cai M, Qian Y, Li Z, Bai H, Han Y, Xiao L, Zhou W, Wang X, Shi B. Combination of IL-1 Receptor Antagonist, IL-20 and CD40 Ligand for the Prediction of Acute Cellular Renal Allograft Rejection. J Clin Immunol 2013;33:280-7. [DOI: 10.1007/s10875-012-9777-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
92 Hirt-Minkowski P, De Serres SA, Ho J. Developing renal allograft surveillance strategies - urinary biomarkers of cellular rejection. Can J Kidney Health Dis. 2015;2:28. [PMID: 26285614 DOI: 10.1186/s40697-015-0061-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
93 Crespo E, Bestard O. Biomarkers to assess donor-reactive T-cell responses in kidney transplant patients. Clin Biochem 2016;49:329-37. [PMID: 26279496 DOI: 10.1016/j.clinbiochem.2015.08.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
94 Seifert ME, Agarwal G, Bernard M, Kasik E, Raza SS, Fatima H, Gaston RS, Hauptfeld-Dolejsek V, Julian BA, Kew CE, Kumar V, Mehta S, Ong S, Rosenblum F, Towns G, Mannon RB. Impact of Subclinical Borderline Inflammation on Kidney Transplant Outcomes. Transplant Direct 2021;7:e663. [PMID: 33511268 DOI: 10.1097/TXD.0000000000001119] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Choi J, Bano A, Azzi J. Biomarkers in Solid Organ Transplantation. Clin Lab Med 2019;39:73-85. [PMID: 30709510 DOI: 10.1016/j.cll.2018.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
96 Ho J, Schaub S, Wiebe C, Gao A, Wehmeier C, Koller MT, Hirsch HH, Hopfer H, Nickerson P, Hirt-Minkowski P. Urinary CXCL10 Chemokine Is Associated With Alloimmune and Virus Compartment-Specific Renal Allograft Inflammation. Transplantation. 2018;102:521-529. [PMID: 28902772 DOI: 10.1097/tp.0000000000001931] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
97 Hirt-minkowski P, Amico P, Ho J, Gao A, Bestland J, Hopfer H, Steiger J, Dickenmann M, Burkhalter F, Rush D, Nickerson P, Schaub S. Detection of Clinical and Subclinical Tubulo-Interstitial Inflammation by the Urinary CXCL10 Chemokine in a Real-Life Setting: Urinary CXCL10 and Allograft Inflammation. American Journal of Transplantation 2012;12:1811-23. [DOI: 10.1111/j.1600-6143.2012.03999.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
98 Menon MC, Murphy B, Heeger PS. Moving Biomarkers toward Clinical Implementation in Kidney Transplantation. J Am Soc Nephrol 2017;28:735-47. [PMID: 28062570 DOI: 10.1681/ASN.2016080858] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 5.6] [Reference Citation Analysis]
99 Krenzien F, ElKhal A, Quante M, Rodriguez Cetina Biefer H, Hirofumi U, Gabardi S, Tullius SG. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation. Transplantation 2015;99:2258-68. [PMID: 26244716 DOI: 10.1097/TP.0000000000000842] [Cited by in Crossref: 55] [Cited by in F6Publishing: 26] [Article Influence: 9.2] [Reference Citation Analysis]
100 Hu J, Xie X, Li Y, Wang S, Feng Q, Wang X, Liang D. A novel noninvasive method to detect rejection after heart transplantation. Braz J Med Biol Res 2012;45:1195-201. [PMID: 23070236 DOI: 10.1590/s0100-879x2012007500164] [Reference Citation Analysis]
101 Behnam Sani K, Sawitzki B. Immune monitoring as prerequisite for transplantation tolerance trials. Clin Exp Immunol 2017;189:158-70. [PMID: 28518214 DOI: 10.1111/cei.12988] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
102 Xu Z, Zhang X, Lau J, Yu J. C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication. Expert Rev Mol Med 2016;18:e16. [PMID: 27669973 DOI: 10.1017/erm.2016.16] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
103 Dharnidharka VR, Al Khasawneh E, Gupta S, Shuster JJ, Theriaque DW, Shahlaee AH, Garrett TJ. Verification of association of elevated serum IDO enzyme activity with acute rejection and low CD4-ATP levels with infection. Transplantation 2013;96:567-72. [PMID: 23823655 DOI: 10.1097/TP.0b013e31829c7cec] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
104 Sigdel TK, Bestard O, Tran TQ, Hsieh SC, Roedder S, Damm I, Vincenti F, Sarwal MM. A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts. PLoS One. 2015;10:e0138133. [PMID: 26367000 DOI: 10.1371/journal.pone.0138133] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
105 Beus JM, Hashmi SS, Selvaraj SA, Duan D, Stempora LL, Monday SA, Cheeseman JA, Hamby KM, Speck SH, Larsen CP, Kirk AD, Kean LS. Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection. PLoS One 2013;8:e71221. [PMID: 23940724 DOI: 10.1371/journal.pone.0071221] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
106 Shen CL, Wu BS, Lien TJ, Yang AH, Yang CY. BK Polyomavirus Nephropathy in Kidney Transplantation: Balancing Rejection and Infection. Viruses 2021;13:487. [PMID: 33809472 DOI: 10.3390/v13030487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
107 Chandraker A, Strom TB. Transplantation: a new molecular approach to the diagnosis of acute rejection. Nat Rev Nephrol 2013;9:631-2. [PMID: 24080796 DOI: 10.1038/nrneph.2013.199] [Reference Citation Analysis]
108 Schlickeiser S, Boës D, Streitz M, Sawitzki B. The use of novel diagnostics to individualize immunosuppression following transplantation. Transpl Int 2015;28:911-20. [PMID: 25611562 DOI: 10.1111/tri.12527] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
109 Ho J, Sharma A, Kroeker K, Carroll R, De Serres S, Gibson IW, Hirt-Minkowski P, Jevnikar A, Kim SJ, Knoll G, Rush DN, Wiebe C, Nickerson P. Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients. BMJ Open 2019;9:e024908. [PMID: 30975673 DOI: 10.1136/bmjopen-2018-024908] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
110 Belard A, Schobel S, Bradley M, Potter BK, Dente C, Buchman T, Kirk A, Elster E. Battlefield to Bedside: Bringing Precision Medicine to Surgical Care. J Am Coll Surg 2018;226:1093-102. [PMID: 29653881 DOI: 10.1016/j.jamcollsurg.2018.02.006] [Reference Citation Analysis]
111 Brunet M, Millán O. Getting immunosuppression just right: the role of clinical biomarkers in predicting patient response post solid organ transplantation. Expert Rev Clin Pharmacol 2021;:1-13. [PMID: 34607521 DOI: 10.1080/17512433.2021.1987882] [Reference Citation Analysis]